726 research outputs found
Evaluation of a smartphone app for forest sample plot measurements
We evaluated a smartphone app (TRESTIMA(TM)) for forest sample plot measurements. The app interprets imagery collected from the sample plots using the camera in the smartphone and then estimates forest inventory attributes, including species-specific basal areas (G) as well as the diameter (D-gM) and height (H-gM) of basal area median trees. The estimates from the smartphone app were compared to forest inventory attributes derived from tree-wise measurements using calipers and a Vertex height measurement device. The data consist of 2169 measured trees from 25 sample plots (32 m x 32 m), dominated by Scots pine and Norway spruce from southern Finland. The root-mean-square errors (RMSEs) in the basal area varied from 19.7% to 29.3% and the biases from 11.4% to 18.4% depending on the number of images per sample plot and image shooting location. D-gM measurement bias varied from -1.4% to 3.1% and RMSE from 5.2% to 11.6% depending on the tree species. Respectively, H-gM bias varied from 5.0% to 8.3% and RMSE 10.0% to 13.6%. In general, four images captured toward the center of the plot provided more accurate results than four images captured away from the plot center. Increasing the number of captured images per plot to the analyses yielded only marginal improvement to the results.Peer reviewe
Entanglement entropy of two disjoint blocks in XY chains
We study the Renyi entanglement entropies of two disjoint intervals in XY
chains. We exploit the exact solution of the model in terms of free Majorana
fermions and we show how to construct the reduced density matrix in the spin
variables by taking properly into account the Jordan-Wigner string between the
two blocks. From this we can evaluate any Renyi entropy of finite integer
order. We study in details critical XX and Ising chains and we show that the
asymptotic results for large blocks agree with recent conformal field theory
predictions if corrections to the scaling are included in the analysis
correctly. We also report results in the gapped phase and after a quantum
quench.Comment: 34 pages, 11 figure
S3b amino acid residues do not shuttle across the bilayer in voltage-dependent Shaker K+ channels
Oligonucleotide Sensor Based on Selective Capture of Upconversion Nanoparticles Triggered by Target-Induced DNA Interstrand Ligand Reaction
Deletion of the S3âS4 Linker in theShaker Potassium Channel Reveals Two Quenching Groups near the outside of S4
HORYZONS trial: protocol for a randomised controlled trial of a moderated online social therapy to maintain treatment effects from first-episode psychosis services.
INTRODUCTION: Specialised early intervention services have demonstrated improved outcomes in first-episode psychosis (FEP); however, clinical gains may not be sustained after patients are transferred to regular care. Moreover, many patients with FEP remain socially isolated with poor functional outcomes. To address this, our multidisciplinary team has developed a moderated online social media therapy (HORYZONS) designed to enhance social functioning and maintain clinical gains from specialist FEP services. HORYZONS merges: (1) peer-to-peer social networking; (2) tailored therapeutic interventions; (3) expert and peer-moderation; and (4) new models of psychological therapy (strengths and mindfulness-based interventions) targeting social functioning. The aim of this trial is to determine whether following 2âyears of specialised support and 18-month online social media-based intervention (HORYZONS) is superior to 18 months of regular care. METHODS AND ANALYSIS: This study is a single-blind randomised controlled trial. The treatment conditions include HORYZONS plus treatment as usual (TAU) or TAU alone. We recruited 170 young people with FEP, aged 16-27 years, in clinical remission and nearing discharge from Early Psychosis Prevention and Intervention Centre, Melbourne. The study includes four assessment time points, namely, baseline, 6-month, 12-month and 18-month follow-up. The study is due for completion in July 2018 and included a 40-month recruitment period and an 18-month treatment phase. The primary outcome is social functioning at 18 months. Secondary outcome measures include rate of hospital admissions, cost-effectiveness, vocational status, depression, social support, loneliness, self-esteem, self-efficacy, anxiety, psychological well-being, satisfaction with life, quality of life, positive and negative psychotic symptoms and substance use. Social functioning will be also assessed in real time through our Smartphone Ecological Momentary Assessment tool. ETHICS AND DISSEMINATION: Melbourne Health Human Research Ethics Committee (2013.146) provided ethics approval for this study. Findings will be made available through scientific journals and forums and to the public via social media and the Orygen website. TRIAL REGISTRATION NUMBER: ACTRN12614000009617; Pre-results
Testing the stress gradient hypothesis in soil bacterial communities associated with vegetation belts in the Andean Atacama Desert
17 PĂĄg.Soil microorganisms are in constant interaction with plants, and these interactions shape the composition of soil bacterial communities by modifying their environment. However, little is known about the relationship between microorganisms and native plants present in extreme environments that are not affected by human intervention. Using high-throughput sequencing in combination with random forest and co-occurrence network analyses, we compared soil bacterial communities inhabiting the rhizosphere surrounding soil (RSS) and the corresponding bulk soil (BS) of 21 native plant species organized into three vegetation belts along the altitudinal gradient (2400-4500Â m a.s.l.) of the Talabre-LejĂa transect (TLT) in the slopes of the Andes in the Atacama Desert. We assessed how each plant community influenced the taxa, potential functions, and ecological interactions of the soil bacterial communities in this extreme natural ecosystem. We tested the ability of the stress gradient hypothesis, which predicts that positive species interactions become increasingly important as stressful conditions increase, to explain the interactions among members of TLT soil microbial communities.This study was funded by ANID FONDECYT Grants 1201278 to MG, 11200319 to DM, 3190194 to JM and 1211893 to VC, and ANID-MILENIO-CN2021-044. LAC was supported by ANID FB21006 and ACT210038. AG was supported by ANID Ph.D. Fellowship 21210808. Research was supported by the "Severo Ochoa Program for Centers of Excellence in R&D" from the Agencia Estatal de InvestigaciĂłn of Spain (Grant SEV-2016-0672 (2017-2021)) to the CBGP. BG-J was supported by a Postdoctoral contract associated to the Severo Ochoa Program. In addition, this research was partially supported by the supercomputing infrastructure of the NLHPC (ECM-02) (Powered@NLHPC).Peer reviewe
Choice of the initial antiretroviral treatment for HIV-positive individuals in the era of integrase inhibitors
BACKGROUND: We aimed to describe the most frequently prescribed initial antiretroviral therapy (ART) regimens in recent years in HIV-positive persons in the Cohort of the Spanish HIV/AIDS Research Network (CoRIS) and to investigate factors associated with the choice of each regimen. METHODS: We analyzed initial ART regimens prescribed in adults participating in CoRIS from 2014 to 2017. Only regimens prescribed in >5% of patients were considered. We used multivariable multinomial regression to estimate Relative Risk Ratios (RRRs) for the association between sociodemographic and clinical characteristics and the choice of the initial regimen. RESULTS: Among 2874 participants, abacavir(ABC)/lamivudine(3TC)/dolutegavir(DTG) was the most frequently prescribed regimen (32.1%), followed by tenofovir disoproxil fumarate (TDF)/emtricitabine (FTC)/elvitegravir(EVG)/cobicistat(COBI) (14.9%), TDF/FTC/rilpivirine (RPV) (14.0%), tenofovir alafenamide (TAF)/FTC/EVG/COBI (13.7%), TDF/FTC+DTG (10.0%), TDF/FTC+darunavir/ritonavir or darunavir/cobicistat (bDRV) (9.8%) and TDF/FTC+raltegravir (RAL) (5.6%). Compared with ABC/3TC/DTG, starting TDF/FTC/RPV was less likely in patients with CD4100.000 copies/mL. TDF/FTC+DTG was more frequent in those with CD4100.000 copies/mL. TDF/FTC+RAL and TDF/FTC+bDRV were also more frequent among patients with CD4<200 cells//muL and with transmission categories other than men who have sex with men. Compared with ABC/3TC/DTG, the prescription of other initial ART regimens decreased from 2014-2015 to 2016-2017 with the exception of TDF/FTC+DTG. Differences in the choice of the initial ART regimen were observed by hospitals' location. CONCLUSIONS: The choice of initial ART regimens is consistent with Spanish guidelines' recommendations, but is also clearly influenced by physician's perception based on patient's clinical and sociodemographic variables and by the prescribing hospital location
Alignment of the Pixel and SCT Modules for the 2004 ATLAS Combined Test Beam
A small set of final prototypes of the ATLAS Inner Detector silicon tracker
(Pixel and SCT) were used to take data during the 2004 Combined Test Beam. Data
were collected from runs with beams of different flavour (electrons, pions,
muons and photons) with a momentum range of 2 to 180 GeV/c. Four independent
methods were used to align the silicon modules. The corrections obtained were
validated using the known momenta of the beam particles and were shown to yield
consistent results among the different alignment approaches. From the residual
distributions, it is concluded that the precision attained in the alignment of
the silicon modules is of the order of 5 micrometers in their most precise
coordinate.Comment: 22 pages, submitted to JINST, 129 author
Interim 2017/18 influenza seasonal vaccine effectiveness: Combined results from five European studies
Between September 2017 and February 2018, influenza A(H1N1)pdm09, A(H3N2) and B viruses (mainly B/Yamagata, not included in 2017/18 trivalent vaccines) co-circulated in Europe. Interim results from five European studies indicate that, in all age groups, 2017/18 influenza vaccine effectiveness was 25 to 52% against any influenza, 55 to 68% against influenza A(H1N1)pdm09, -42 to 7% against influenza A(H3N2) and 36 to 54% against influenza B. 2017/18 influenza vaccine should be promoted where influenza still circulates
- âŠ